Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry

Annals of Surgery

Volumn 244, Issue 6, 2006, Pages 854-862

  Lerut, Jan ^a   Orlando, Giuseppe ^a   Adam, René ^b   Sabbà, Carlo ^c   Pfitzmann, Robert ^d   Klempnauer, Jurgen ^f   Belghiti, Jacques ^e   Pirenne, Jacques ^g   Thevenot, Thierry ^h   Hillert, Christian ⁱ   Brown, Colin M ^k   Gonze, Dominique ^a   Karam, Vincent ^b   Boillot, Olivier ^j  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Centre Hépatobiliaire Paul Brousse   (France)

^c UNIVERSITY OF BARI   (Italy)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f BEAUJON HOSPITAL   (France)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j EDOUARD HERRIOT HOSPITAL   (France)

^k Cliniques Universitaires St Luc ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; BILE DUCT DISEASE; BILE DUCT NECROSIS; BLEEDING; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEPATOBILIARY DISEASE; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NECROSIS; PALLIATIVE THERAPY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; SEPSIS; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; EUROPE; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 33751346601     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000247258.35406.a4     Document Type: Article

References (46)

1. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91:66-67.
2. Fuchizachi U, Miyamori H, Kitagawa S, et al. Hereditary haemorrhagic telangiectasia. Lancet. 2003;362:1490-1494.
3. Haitjema T, Westermann CJJ, Overtoom TTC, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Arch Intern Med. 1996;156:714-719.
4. Weik C, Greiner L. The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Scand J Gastroenterol. 1999;34:1241-1246.
5. Saurin JC, Dumortier J, Menard Y, et al. Les malformations vasculaires hépatiques de la maladie de Rendu-Osler. Gastroenterol Clin Biol. 2000;24:89-93.
6. Buscarini E, Buscarini L, Danesino C, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol. 1997;26:111-118.
7. Bauer T, Britton P, Lomas D, et al. Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia. J Hepatol. 1995;22:586-590.
8. Boillot O, Bianco F, Viale JP, et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology. 1999;116:187-192.
9. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology. 2003;42:265-269.
10. Ianora AA, Memeo M, Sabba C, et al. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology. 2004;230:250-259.
11. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000;343:931-936.
12. Azoulay D, Precetti S, Emile JF, et al. Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience. Gastroenterol Clin Biol. 2002;26:828-834.
13. Hillert C, Broering DC, Gundlach M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation. Liver Transpl. 2001;7:266-268.
14. Caselitz M, Wagner S, Chavan A, et al. Clinical outcome of transfemoral embolization in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut. 1998;42:123-126.
15. Neumann UP, Knoop M, Langrehr JM, et al. Effective therapy for hepatic M: Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int. 1998;11:323-326.
16. Pfitzmann R, Heise M, Langrehr JM, et al. Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation. 2001;72:237-241.
17. Le Corre F, Golkar B, Tessier C, et al. Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia: hemodynamic study. J Clin Anesth. 2000;12:339-342.
18. McInroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol. 1998;170:413-415.
19. Odorico JS, Hakim MN, Becker YT, et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg. 1998;4:483-490.
20. Saxena R, Hytiroglou P, Atillasoy EO, et al. Coexistence of hereditary hemorrhagic telangiectasia and fibropolycystic liver disease. Am J Surg Pathol. 1998;22:368-372.
21. Aseni P, Vertemati M, Minola E, et al. Massive haemoptysis after living donor liver transplantation. J Clin Pathol. 2003;56:876-878.
22. Sabba C, Gallitelli M, Longo A, et al. Orthotopic liver transplantation and hereditary hemorrhagic telangiectasia: do hepatic vascular malformations relapse? A long-term follow up study on two patients. J Hepatol. 2004;41:685-690.
23. Bueres Dominguez I, Annet L, Waignein F, et al. Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation. Liver Int. 2005;25:677-679.
24. Argyriou L, Pfitzmann R, Wehner LE, et al. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia. Liver Transpl. 2005;11:1132-1135.
25. Thevenot T, Vanlemmens C, Di Martino V, et al. Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia. Liver Transpl. 2005;11:834-838.
26. Lesca G, Plauchu H, Coulet F, et al. French Rendu-Osler Network. Molecular screening of ALK /ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat. 2004;23:289-299.
27. http://orphanet.infobiogen.fr/associations/AMRO/PP6. html.
28. Berg J, Porteous M, Reinhardt D, et al. Hereditary hemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet. 2003;40:585-590.
29. Abdalla SA, Pece-Barbara N, Vera S, et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet. 2000;9:1227-1237.
30. Piantanida M, Buscarini E, Dellavecchia C, et al. Hereditary hemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT 1 or HHT2. J Med Genet. 1996;33:441-443.
31. Ingrosso M, Sabba C, Pisani A, et al. Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study. Endoscopy. 2004;36:1074-1079.
32. Kjeldsen AD, Oxhoj H, Andersen PE, et al. Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia. J Intern Med. 2000;248:255-262.
33. Plauchu H, de Chadarevian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291-297.
34. Sawabe M, Arai T, Esaki Y, et al. Three-dimensional organization of the hepatic microvasculature in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med. 2001;125:1219-1223.
35. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med. 1986;110:331-335.
36. Buscarini E, Saurin JC, Reduzzi, L, et al. Focal lesions in liver involvement in HHT [Abstract 39]. VI HHT-ROW Scientific Conference, Lyon, France, 2005.
37. Spurny OM, Pierce JA, Cardiac output in systemic arteriovenous fistula complicated by heart failure. Am Heart J. 1961;61:21-24.
38. Whiting J, Korzenik J, Miller F, et al. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Rad. 2000;11:855-858.
39. Livneh A, Langevitz P, Morag B, et al. Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. South Med J. 1988;81:1047-1049.
40. Hashimoto M, Tate E, Nishii T, et al. Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol. 2003;26:177-180.
41. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2003;9:1231-1243.
42. Buscarini E, Saurin JC, Reduzzi, L, et al. Prevalence of cholestasis in liver involvement in HHT [Abstract 38]. VI HHT-ROW Scientific Conference, Lyon, France, 2005.
43. Young L, Garcia-Tsoa G, Henderson KJ, et al. Long-term outcomes in patients with symptomatic liver hereditary hemorrhagic telangiectasia HHT [Abstract 40]. VI HHT-ROW Scientific Conference, Lyon, France, 2005.
44. Vauthey JN, Tomczak RJ, Helmberger T, et al. The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology. 1997;113:1390-1401.
45. Faughnan ME, Lui YW, Wirth JA, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest. 2000;117:31-38.
46. Svetliza G, De la Canal A, Beveraggi E, et al. Lung transplantation in a patient with arteriovenous malformations. J Heart Lung Transplant. 2002;21:506-508.